Summary
- Current Price
- As of today, MGX price is $1.35, up +0.75% on
- Current Price All-Time High
- MGX price is currently -89.40% below its historical high of $12.74 set on
- Market Cap
- MGX current market cap is $51M, up +1.95% over the past 365 days
- PE Ratio
- MGX PE ratio is unknown
- Revenue
- MGX current annual revenue is $25.21M, down -51.79% year-over-year
- Next Earnings
- As of today, the next earnings release for MGX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Metagenomi, Inc. |
| Ticker | NASDAQ: MGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | metagenomi.co |
| Employees | 176 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.35 | ||
| Price, 1D Change | +0.75% | |
| $51M | ||
| - | ||
| - | ||
| 1.14 | ||
| $25M | ||
| Revenue, 1Y Change | -51.79% | |
| -$2.36 | ||
| EPS, 1Y Change | -13.07% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.36 | ||
| EPS Estimate | N/A | -$2.17 |
| EPS Est. Change | N/A | +7.86% |
| $25.21M | ||
| Revenue Estimate | N/A | $22.22M |
| Revenue Est. Change | N/A | -11.84% |
| $1.35 | ||
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +566.67% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.48 | -$2.09 | +15.97% | |
| -$2.34 | -$2.36 | -0.91% | |
| -$2.17 | N/A | +7.86% | |
| -$1.67 | N/A | +29.10% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $51.70M | $52.30M | +1.15% | |
| $28.63M | $25.21M | -11.94% | |
| $22.22M | N/A | -11.84% | |
| $21.50M | N/A | -14.70% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +1.50% | ||
| - | ||
| +1.95% | ||
| - | ||
| -51.79% | ||
| +46.57% | ||
| -13.07% | ||
| -102.77% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.35 | ||
| $1.90 | ||
| SMA 200 vs Price | +40.47% | |
| $1.50 | ||
| SMA 50 vs Price | +11.36% | |
| 1.14 | ||
| $0.10 | ||
| 42.36 | ||
| 53.96% | ||
| 79.67% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $25.21M | ||
| -$2.36 | ||
| $19.89M | ||
| 78.91% | ||
| -$96.01M | ||
| -380.85% | ||
| -$87.87M | ||
| -348.54% | ||
| -$90.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.26 | ||
| 7.22 | ||
| 7.22 | ||
| - | ||
| 2 | ||
| -1.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 2.01 | ||
| 0.32 | ||
| 0.77 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $158.60M | ||
| $160.80M | ||
| $233.28M | ||
| $165.54M | ||
| $74.68M | ||
| $22.93M | ||
| $40.66M | ||
| $6.03M | ||
| $1.49M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $113.08M | ||
| $115.91M | ||
| $5.32M | ||
| $0.00 | ||
| $5.32M | ||
| $0.00 | ||
| -$58.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$88.89M | ||
| $103.53M | ||
| -$356.00K | ||
| $574.00K | ||
| -$89.47M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Wells Fargo | → | |
| Chardan Capital | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with MGX
FAQ
What is the ticker symbol for Metagenomi, Inc.?
The ticker symbol for Metagenomi, Inc. is NASDAQ:MGX
Does Metagenomi, Inc. pay dividends?
No, Metagenomi, Inc. does not pay dividends
What sector is Metagenomi, Inc. in?
Metagenomi, Inc. is in the Healthcare sector
What industry is Metagenomi, Inc. in?
Metagenomi, Inc. is in the Biotechnology industry
What country is Metagenomi, Inc. based in?
Metagenomi, Inc. is headquartered in United States
When did Metagenomi, Inc. go public?
Metagenomi, Inc. initial public offering (IPO) was on April 6, 2006
Is Metagenomi, Inc. in the S&P 500?
No, Metagenomi, Inc. is not included in the S&P 500 index
Is Metagenomi, Inc. in the NASDAQ 100?
No, Metagenomi, Inc. is not included in the NASDAQ 100 index
Is Metagenomi, Inc. in the Dow Jones?
No, Metagenomi, Inc. is not included in the Dow Jones index
When was Metagenomi, Inc. last earnings report?
Metagenomi, Inc.'s most recent earnings report was on August 13, 2025
When does Metagenomi, Inc. report earnings?
The date for Metagenomi, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MGX Official Website metagenomi.co
- MGX Profile on Yahoo Finance finance.yahoo.com/quote/MGX
- MGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mgx